Welcome to Medpharm Publications

Clariant launches Prenylium™ – a sustainably-sourced root-powered active ingredient for premium well-ageing skincare

Clariant Active Ingredients launches Prenylium – the first product unveiled thanks to its new partnership with French biotechnology company, Plant Advanced Technologies (PAT). Rich in rare prenylated flavonoids content, Prenylium is a unique Morus alba tree root extract, highly efficient at protecting the skin matrisome from degradation that occurs with time and UV exposure. It also helps prevent signs of ageing by visibly reducing the appearance of existing wrinkles and smoothing skin.

Positive results in Phase III study for Allegra®/Telfast® in patients with allergic rhinitis

The results of the Phase III, single-centre, sequential and parallel-group, double-blind, randomised, placebo-controlled FEXPOLSAR study evaluating the efficacy and safety of Allegra®/Telfast® in adults with allergic rhinitis (AR) symptoms aggravated by a common component of air pollution were announced at the World Allergy Congress (WAC) in Lyon, France. The study demonstrated that Allegra®/Telfast® 180 mg significantly decreased pollution-exacerbated AR symptoms by 21%in adult allergic rhinitis patients. 

Obesity in patients – the importance of broaching the topic and the benefits of pharmacotherapy as an adjunct

The World Health Organization has found that more than 28% of adults in South Africa are obese, the highest obesity rate amongst sub-Saharan African countries. Obesity is widely acknowledged to be associated with many health risks and diseases including type 2 diabetes, heart disease, stroke, hypertension, joint pain and certain cancers. Dr Daksha Jivan, an endocrinologist in the Division of Endocrinology at Charlotte Maxeke Johannesburg Academic Hospital, says that healthcare practitioners need to introduce the topic of obesity with their patients and make them aware of their BMI, tell them about the potential risks and problems associated with obesity, screen them for complications early and make them aware that there is medication available to assist them. “I can’t stress enough how important it is for HCPs to broach the topic with their patients,” she says.3

Achieving a sustainable Festive Season

Keeping the holidays eco-friendly may seem like a daunting and perhaps, at times, even a somewhat impossible task. However, there are entirely manageable strategies to ensure that you can celebrate the Festive Season fully while also achieving sustainability. The Festive Season is often a time where waste increases. Many products that are not eco-friendly and/or biodegradable are used in large supply. The increased use of plastics, electricity, water and cleaning products lead to a real threat on sustainability – putting your health, your loved ones’ health, and the environment at risk.

Notification of permanent price reduction for Gemzar 200 mg and Gemzar 1 g

Eli Lilly (SA) (PTY) Limited is pleased to announce a 36.6% permanent price reduction for Gemzar 200 mg and for Gemzar 1 g effective 29 November 2019. Gemzar has been in South Africa for 24 years for the management of NSCLC, breast cancer, pancreatic cancer, recurrent epithelial ovarian cancer, and transitional cell bladder cancer.

Medpharm Publications was founded in 1988 and has established itself as the largest medical and pharmaceutical journal publisher in South Africa.
With a publications list of more than ten titles comprising of over fifty journal editions, Medpharm Publications reach more than 40 000 healthcare workers countrywide with printed editions, and has established a global audience with the online editions.
The majority of Medpharm Publications’ journals are associated with professional or scholarly societies and acts as the official South African mouthpiece in the associated discipline. All journals are web-based, most of which are fully peer-reviewed, with five titles accredited by the South African Department of Higher Education and Training (DHET) to earn research subsidies for academic departments.
As a publisher, passionate about journal publishing, we believe that South African researchers and clinicians can and will make a significant contribution to world medical literature.

Wildcard SSL